Early PKD Observational Cohort Study
University of Kansas Medical Center · with National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · NCT02936791
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 4–35 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 250
- US sites recruiting
- 3
- Study start
- April 2016
- Record last updated
- April 27, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This observational study will collect blood and urine and clinical information from individuals with early-stages of polycystic kidney disease (PKD), their unaffected siblings and normal volunteers to create a biobank, also called a biorepository. The long-term goal is to develop new knowledge on biological markers or biomarkers that indicate changes in the disease progression. An understanding of biomarkers for early renal cyst growth will benefit PKD patients as new therapies are being developed and tested.
Conditions: Polycystic Kidney Disease
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Inclusion for early stage autosomal dominant polycystic kidney disease (ADPKD):
- Family history of PKD
- All races and ethnic groups
- Glomerular filtration rate (GFR) >80 ml/min per 1.73 m2
- Inclusion for Healthy Volunteers:
- Male or female with no family history of kidney disease
- All races and ethnic groups
- Normal GFR
Exclusion Criteria
- Non-insulin or insulin-dependent diabetes mellitus
- Systemic illness (i.e.systemic lupus erythematosus, vasculitis)
- Unable to provide written informed consent
- Unavailable for magnetic resonance imaging (MRI) and blood/urine collection
Recruiting US locations
University of Chicago
Chicago, IL 60637
Site contact: Arlene Chapman, MD · Achapman1@medicine.bsd.uchicago.edu
University of Kansas Medical Center
Kansas City, KS 66160
Site contact: Cathy Creed, RN · 913-588-0053 · ccreed@kumc.edu
Children's Mercy Hospital
Kansas City, MO 64108
Site contact: Megan Mains, BSN · 816-760-5918 · mmmains@cmh.edu
Study contacts (from the official record)
- Cathy Creed, RN · 913-588-0053 · ccreed@kumc.edu
Similar studies in Illinois
All healthy volunteers studies in Illinois →- RecruitingHealthy volunteers
J-RISE: Relevant Implementation Strategies to Eliminate the Social and Structural Barriers to HIV Services Among Justice-involved Black Men Who Have Sex With Men and Other Key Populations
University of Chicago
- Location
- Chicago, IL
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Melrose Park, IL + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
A Study to Assess Safety, Tolerability, and How Single and Multiple Injections or Infusions of ABBV-313 Affects the Body of Adult Participants
AbbVie
- Location
- Grayslake, IL + 1 other US site
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1
A Study to Evaluate the Safety and Pharmacokinetics of Multiple Doses Upadacitinib, Tofacitinib, and Baricitinib in Healthy Adult Volunteers
AbbVie
- Location
- Grayslake, IL
- Eligibility basics
- Ages 18–65